Clinical trial
Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
NCT00003710 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00003710 |
|---|---|
| Title | Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I and Pharmacokinetic Study of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Solid Tumors |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, mitomycin C |
| Enrollment | 12 |
| Start date | Aug 1, 1998 |
| Primary completion | May 1, 2001 |
| Completion | May 1, 2001 |
| First posted | Apr 9, 2004 |
| Last update posted | Aug 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: